gvtcx

NHSBT1202 - BBMR Stem Cell Services

NHS Blood & Transplant Published 30 Jan 2019 Contracts Finder

key details

Statuscomplete
Category (CPV) 85100000
RegionLondon
Deadline25 Oct 2018
Contract start1 Apr 2019
Contract end31 Mar 2021
Procedureopen
SME suitableNo
OCIDocds-b5fd17-3c4213bc-f29b-45a9-ad12-06b88d151c40

Award

SupplierValueDateStatus
The London Clinic £524,072 25 Jan 2019 active

description

The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant. The Northern Ireland and Scottish Blood Transfusion Services are participants in the service provided by the BBMR.

The BBMR supports HSC Clinical Transplantation Programmes for UK and International patients. It recruits prospective stem cell donors from the blood donor population. The donors are tissue typed and they are then available to be searched by accredited Transplant Centres or laboratories acting on their behalf for patients with leukaemia and other blood disorders. After further identification testing a donor may be selected as the final donor. The BBMR collects HSC products from donors between the ages of 18 and 60.

The finally selected donor is counselled and informed consent for the donation obtained. Donor counselling is currently performed by the BBMR in accordance with Human Tissue Authority (HTA) and World Marrow Donor Association (WMDA) requirements. Responsibility for this service can be undertaken by the service provider.

The donor must be medically assessed and fitness to donate the HSC product determined. The medical assessment of the donor includes the risk of disease transmission to the recipient.

The source of stem cells for First and Subsequent donations is from the Bone Marrow under General Anaesthetic (GA) as an inpatient, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF) as an outpatient procedure. Subsequent donations for the same patient may also include blood lymphocytes.

For a peripheral blood stem cell collection donors receive a short course of G-CSF, 4 or 5 days. The successful bid service provider will prescribe G-CSF as Lenograstim, Granocyte®.

BBMR require a Collection Centre, located in the Central London area

The service provider will procure, label and issue the HSC product, for distribution under direction from BBMR. .

Additional information:

NHSBT will be running a tender through Bravo Solutions ePortal, please follow the instructions below to register on the system. This will be published on 25th September 2018 and will close on 25th October 2018.

To register your company on the eSourcing portal (this is only required once) - Browse to the eSourcing Portal at https://nhsbt.bravosolution.co.uk - Click the "Register now!" link - Accept the terms and conditions and click "continue" - Enter your correct business and user details - Note the username you chose and click "Save" when complete - You will shortly receive an email with your unique password (please keep this secure).

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
24 Sept 2018 Tender (tender) · f8b9e21b-9c69-4fbe-8fe9-f540203e9dfb-242346
30 Jan 2019 Award (award) · 4655d698-64fd-4624-83cb-50bfcb17f727-266819

more from NHS Blood & Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.